Newsroom

Sorted by: Latest

-

Paysafe Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – PSFE       

LOS ANGELES--(BUSINESS WIRE)--Paysafe Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – PSFE...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF - September 11.02.2026 MSEP.LN IE0009DRFET8 100,002.00 USD 2,715,465.74 27.154  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Rising Dividend Achievers UCITS ETF 11.02.2026 RDVY LN IE000K5F6EL4 775,002.00 USD 17,847,698.95 23.029  ...
-

Pret A Manger Brings Back 2016 Prices on Fan-Favorite Menu Items

NEW YORK--(BUSINESS WIRE)--Pret A Manger (Pret), known for organic coffee and freshly made food, is turning back the clock and relieving wallets with the “2016 Rewind Menu.” The limited-time offer brings select fan-favorite menu items back to their 2016 prices at Pret shops across New York City. The deal was inspired by the recent cultural nostalgia for 2016 — a moment many associate with simpler routines and more affordable daily pleasures. Starting Feb. 12, guests can find throwback pricing o...
-

Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026

EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its fourth quarter and full year 2025 financial results before the market opens on Friday, February 27, 2026. Management will host a conference call for the investment community the same day at 8:30 AM ET (5:30 AM PT) to discuss the result...
-

PHINIA Reports Fourth Quarter and Full Year 2025 Results

AUBURN HILLS, Mich.--(BUSINESS WIRE)--PHINIA Inc. (NYSE: PHIN), a leader in premium fuel systems, electrical systems, and aftermarket solutions, today reported results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter Highlights: Net sales of $889 million, an increase of 6.7% compared with Q4 2024. Excluding the impacts of foreign currency and acquisitions, increases of $25 million and $12 million, respectively, net sales increased $19 million or 2.3%, primarily drive...
-

FICS® Recognized in HousingWire’s HWTech100 List for 13th Consecutive Year

DALLAS--(BUSINESS WIRE)--FICS (Financial Industry Computer Systems, Inc.) has been named to the HousingWire HWTech100 list for the 13th consecutive year....
-

Lincoln Electric Reports Fourth Quarter and Full Year 2025 Results

CLEVELAND--(BUSINESS WIRE)--Lincoln Electric Holdings, Inc. (the “Company”) (Nasdaq: LECO) today reported fourth quarter 2025 net income of $136.0 million, or diluted earnings per share (EPS) of $2.45, which includes special item after-tax net charges of $10.6 million, or $0.20 EPS. This compares with prior year period net income of $140.2 million, or $2.47 EPS, which included special item after-tax net charges of $5.8 million, or $0.10 EPS. Excluding special items, fourth quarter 2025 adjusted...
-

GE HealthCare management to present at upcoming investor conferences

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences. Citi’s 2026 Unplugged MedTech and Life Sciences Access Day – Thursday, February 26, 2026 at 9:30 am ET/8:30 am CT Barclays 28th Annual Global Healthcare Conference – Tuesday, March 10, 2026 at 8:00 am ET/7:00 am CT Webcasts for each event can be accessed on the GE HealthCare website: https://investor.gehealthcare.com/news-events/ev...
-

Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market

DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) (“Alkermes”) and Avadel Pharmaceuticals plc (Nasdaq: AVDL) (“Avadel”) today announced Alkermes’ completion of its acquisition of Avadel, a commercial-stage biopharmaceutical company. The acquisition adds Avadel’s FDA-approved product, LUMRYZ®, to Alkermes’ commercial portfolio, and provides Alkermes with a commercial organization experienced in this disease state. This strategic move accelerates Alkermes’ entry into the sleep medicine market...